AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016
Feb 4, 2016
10216_dirs_2016-02-03_2c8f02fe-efd2-47ba-bc2a-eeaeb0d5451d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-12-15
Reporting Person: PRINS RICHARD K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-15 | Common Stock | G | 350 | $0.00 | Disposed | 28600 | Direct |
More from Amphastar Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Investor Presentation
2026
Jun 3
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17